Inventor
Philippe Muller
Inventor
Ande, FR
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes23%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
Y02PClimate change mitigation technologies in the production or processing of goods5%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
10,829,494Macrocyclic deaza-purinones for the treatment of viral infections202010,280,180Macrocyclic purines for the treatment of viral infections201910,280,167Purine derivatives for the treatment of viral infections201910,266,543Macrocyclic deaza-purinones for the treatment of viral infections201910,221,157Pyrimidine derivatives for the treatment of bacterial diseases20199,725,432'Pyrimidine derivatives for the treatment of bacterial diseases'20179,556,176'Purine derivatives for the treatment of viral infections'20178,883,837'Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication'20148,278,455'5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication'20128,178,694'Heterocyclylaminoalkyl substituted benzimidazoles'20128,044,073'Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication'20118,034,835'1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs'20117,928,097'Photoreactive compounds and compositions'20117,884,215'2-substituted benzimidazoles'20117,449,463'Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication'20087,176,327'Photoreactive compounds and compositions'20076,420,387'Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives'20026,169,096'Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives'20016,037,350'Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2019Patents assigned to JANSSEN PHARMACEUTICA NV (5)· patent assignee history
2000–2020Based in Ande, FR· patent location history
2002Based in And, FR· patent location history
2007–2011Based in Hitchin, GB· patent location history
2008–2012Patents assigned to TIBOTEC PHARM LTD (4)· patent assignee history
2008–2017Based in Andé, FR· patent location history
2011–2014Patents assigned to MULLER PHILIPPE (5)· patent assignee history
2011–2014Patents assigned to BONFANTI JEAN-FRANCOIS (4)· patent assignee history
2017–2019Patents assigned to JANSSEN SCIENCES IRELAND UC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 5 | 2000–2019 |
| MULLER PHILIPPEself | 5 | 2011–2014 |
| BONFANTI JEAN-FRANCOIS | 4 | 2011–2014 |
| JANSSEN SCIENCES IRELAND UC | 4 | 2017–2019 |
| TIBOTEC PHARM LTD | 4 | 2008–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ande, FR | 8 | 2000–2020 |
| Andé, FR | 8 | 2008–2017 |
| Hitchin, GB | 2 | 2007–2011 |
| And, FR | 1 | 2002 |